The elusive 8-fluoroadenosine

Tetrahedron Letters

Volumn 39, Issue 40, 1998, Pages 7231-7234

  Barrio, Jorge R ^b   Namavari, Mohammad ^b   Keen, Randy E ^a,b   Satyamurthy, Nagichettiar ^b  

^a Keen Angstrom Materials Research   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Enzymes and Enzyme reactions; Fluorine and compounds; Nucleosides; Purines

Indexed keywords

ADENOSINE DERIVATIVE;

ARTICLE; CHEMICAL ANALYSIS; CHEMICAL REACTION; DRUG SYNTHESIS;

EID: 0032191562     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0040-4039(98)01594-9     Document Type: Article

References (43)

1. 1. (a) Barrio, J.R., Namavari, M., Phelps, M.E.; Satyamurthy, N. J. Org. Chem. 1996, 61, 6084.
2. (b) Barrio, J.R.; Namavari, M.; Phelps, M.E.; Satyamurthy, N. J. Am. Chem. Soc. 1996, 118, 10408.
3. 2. Ikehara, M.; Yamada, S. Chem. Pharm. Bull. 1971, 19, 104.
4. 3. Kobayashi, Y.; Kumadaki, I.; Oshawa, A.; Murakami, S. J. Chem. Soc., Chem. Commun. 1976, 430.
5. 4. Stolarski, R.; Pohorille, A.; Dudycz, L.; Shugar, D. Biochim. Biophys. Acta 1980, 610, 1.
6. 19F NMR and UV spectroscopy. Barrio, J.R. Unpublished results.
7. (b) Mounetou, E.; Debiton, E.; Buchdahl, C.; Gardette, D.; Gramain, J-C.; Maunzis, J-C.; Veyre, A.; Madelmont, J-C. J. Med. Chem. 1997, 40, 2902.
8. (c) Gosselin, G.; Bergogne, M-C.; de Rudder, J.; De Clercq, E.; Imbach, J-L. J. Med. Chem. 1986, 29, 203.
9. 6. (a) Brennan, M.B. C & E News October 14, 1996, 31.
10. (b) Cowan, D.A. "Protein Stability at High Temperatures" Essays in Biochemistry 1995, 29, 193. Apps, DK, Tipyon, KF eds, Portland Press, London.
11. (c) Faber, K.; Franssen, M.C.R. Trends Biotech. 1993, 11, 461.
12. (d) Dordick, J.S.; Principles and Applications of Nonaqueous Enzymology, Applied Biocatalysis 1991, 1, 1. Blanch, HW, Clark, DS eds, Marcel Dekker, New York.
13. R screening set)] as suitable biocatalyst for deprotection of sugar acylated nucleosides in neutral aqueous/organic solutions. Biocatalysts tested have varying activities and specifities for a range of different purine, acyclopurine and pyrimidine nucleosides dependent on solvent and temperature.
14. 8. Two centriplus-10 (10,000 MW cut off; Amicon Corp.) devices were washed with 1.0 mL 18 Mohm water to remove any residual preservatives prior to loading sample. Each centriplus-10 was loaded with the reaction mixture and spun at 6,000 rpm in an ultracentrifuge for 12 h at 4°C to dryness. An additional 1.0 mL 50 mM MOPS buffer, pH 7.0 was added to each centriplus-10 and spun at 6,000 rpm for 4h at 4°C. The ESL-001-02 biocatalyst was then recovered from the retentate and stored at 4°C in the 50 mM MOPS, pH 7.0 for reuse. The ESL-001-02 biocatalyst was reused many times (>6) in the deprotection of 2 with little or no apparent loss in activity.
15. 9. Slow decomposition of 1 may occur during chromatography for which a rapid purification procedure is necessary.
16. 4F = 286.0952; Found: 286.0955.
17. 11. Alderfer, J.L.; Loomis, E.; Zielinski, T.J. Biochemistry 1982, 21, 2738.
18. 12. Weigert, F.J.; Robert, J.D. J. Am. Chem. Soc. 1967, 89, 2967.
19. 13. Lichter, R.L.; Washylishen, R.E. J. Am. Chem. Soc. 1975, 97, 1808.
20. 14. (a) Birmbaum, G.I.; Lassota, P.; Shugar, D. Biochemistry 1984, 23, 5048.
21. (b) Stolarski, R.; Dudycz, L.; Shugar, D. Eur. J. Biochem. 1980, 108, 111.
22. 13C-NMR (Nair, V.; Young, D.A. Magnet. Res. Chem. 1987, 25, 937), it has been shown that unprotected nucleosides in the syn conformation have Δ(C-2'-C-3') of less than 0.5 ppm, and those preferentially in the anti conformation exhibit Δ(C-2'-C-3') greater than 2.8 ppm.
23. (d) Vesugi, S.; Ikehara, M. J. Am. Chem. Soc. 1977, 99, 3250.
24. 15. (a) Orozco, M.; Lluis, C.; Mallol, J.; Canela, E.I.; Franco, R. J. Pharm. Sci. 1990, 79, 133.
25. (b) Ikehara, M.; Uesugi, S.; Yoshida, K. Biochemistry 1972, 11, 830.
26. 16. Fluorine has a small van der Waals radius (1.35 Å). See: Pauling, L. The Nature of the Chemical Bond, 3rd ed.; Cornell University Press: Ithaca, NY, 1960; p 260.
27. 17. (a) Hampton, A.; Harper, P.J.; Sasaki, T. Biochemistry 1972, 11, 4736.
28. (b) Zemlicka, J. J. Am. Chem. Soc. 1975, 97, 5896.
29. Ado = 16.80 min).
30. 19. (a) Frick, L.; Neela, J.P.; Wolfenden, R. Bioorg. Chem. 1987, 15, 100.
31. 2 may have been in question.
32. 20. (a) Maguire, M.H.; Sim, M.K. Eur. J. Biochemistry 1971, 23, 22.
33. (b) Kurz, L.C.; Frieden, C. Biochemistry 1983, 22, 382.
34. (c) Weiss, P.M.; Cook, P.F.; Hermes, J.D.; Cleland, W.W. Biochemistry 1987, 26, 7378.
35. (d) Centelles, J.D.; Franco, R.; Bozal, J. Neuroscience Res. 1988, 19, 258.
36. 21. Kurz, L.C.; La Zard, D.; Frieden, C. Biochemistry 1985, 24, 1342.
37. 22. Chang, Z.; Nygaard, P.; Chinault, A.C.; Kellems, R.E. Biochemistry 1991, 30, 2273.
38. 23. Sideraki, V.; Mohamedali, K.A.; Wilson, D.K.; Chang, Z.; Kellems, R.E.; Quiocho, F.A.; Rudolph, F.B. Biochemistry 1996, 35, 7862.
39. 24. Kurz, L.C.; Moix, L.; Riley, M.C.; Frieden, C. Biochemistry 1992, 31, 39.
40. 25. We determined the pKa of 1 and Ado in aqueous solution using a micro titrimetric procedure (1, pKa = 2.95 vs 3.59 for Ado; Lit. pKa value for Ado: 3.52; see Clauwaert, J.; Stockx, J.; Z. Naturforsch 1968, 23b, 25).
41. 26. Orozco, M.; Lluis, C.; Mallol, J.; Canela, E.I.; Franco, R. Quant. Struct.-Act. Relat. 1989, 8, 109.
42. 27. Secrist III, J.A.; Shortnacy, A.T.; Montgomery, J.A. J. Med. Chem. 1985, 28, 1740.
43. 28. Gambhir, S.S.; Barrio, J.R.; Srinivasan, A.; Iyer, M., Wu, L.; Namavari, M.; Satyamurthy, N.; Green, L.A.; Parrish, C.; McLaren, D.; Borghei, A.R.; Cherry, S.R.; Phelps, M.E., Hershman, H.R. J. Nucl. Med. 1998, in press.